Narus Financial Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$506K Hold
437
– – 0.13% 107
2026
Q2
$524K Sell
437
-54
-11% -$55.2K 0.13% 106
2026
Q1
$452K Sell
491
-1
-0.2% -$1.01K 0.12% 106
2025
Q4
$529K Buy
492
+93
+23% +$88.9K 0.15% 89
2025
Q3
$304K Buy
+399
New +$297K 0.08% 134

Other funds holding LLY

Narus Financial Partners's LLY Position: Q3 2026 in Review

Narus Financial Partners held its Eli Lilly (LLY) position steady in Q3 2026 at 437 shares worth $506K. The position accounts for 0.13% of the portfolio, ranked #107.

Narus Financial Partners first reported a position in LLY in Q3 2025 and has held it in 5 quarters since. The position peaked at $529K in Q4 2025. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Narus Financial Partners held 437 shares of Eli Lilly worth $506K as of Q3 2026.
  • Narus Financial Partners left its Eli Lilly share count unchanged in Q3 2026.
  • Eli Lilly made up 0.13% of Narus Financial Partners's portfolio in Q3 2026, its #107 holding.
  • Narus Financial Partners first reported a position in Eli Lilly in Q3 2025 and has held it in 5 quarters since.
  • Narus Financial Partners's Eli Lilly position peaked at $529K in Q4 2025.
  • 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Narus Financial Partners's 13F filing for Q3 2026, filed 19 Oct 2026.